Skip to content

DuraGen® Plus DP5013Recalls & reported problems

Integra Lifesciences Corporation · DuraGen® Plus Dural Regeneration Matrix, 1 in x 3 in (2.5 cm x 7.5 cm) · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 10381780070924), received between Apr 16, 2025 and Apr 29, 2025 — classified as 5 injuries, 1 malfunction.

The most frequently reported specific device problem is “Failure to Seal” (6 reports).

1 other recall cover devices cleared under the same FDA submission (K032693); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 6 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520266
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Seal6

Patient problems

  • Cerebrospinal Fluid Leakage6

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 29, 2025Failure to Seal; Failure to Seal

    N/A.

    Patient problems: Cerebrospinal Fluid Leakage

    MAUDE report 21926723 ↗
  • InjuryApr 29, 2025Failure to Seal; Failure to Seal

    N/A.

    Patient problems: Cerebrospinal Fluid Leakage

    MAUDE report 21926614 ↗
  • InjuryApr 29, 2025Failure to Seal; Failure to Seal

    N/A.

    Patient problems: Cerebrospinal Fluid Leakage

    MAUDE report 21926496 ↗
  • InjuryApr 16, 2025Failure to Seal; Failure to Seal

    THIS REPORT IS 3 OF 3 AND LINKED TO MFG REPORT NUMBERS 1121308-2025-00011 AND 1121308-2025-00013: A FACILITY REPORTED THAT 3 DURA LEAKS (CSF LEAKAGE) WITH THE SAME LOT NUMBER OF THE DURAGEN PLUS DURAL REGENERATION MATRIX (DP5013) OCCURRED POST SURGERY. NO PRODUCT HAS BEEN REMOVED FROM PATIENTS, BUT PRODUCT WITH THE SAME LOT NUMBER HAS BEEN REMOVED FROM CIRCULATION.

    Patient problems: Cerebrospinal Fluid Leakage

    MAUDE report 21851904 ↗
  • MalfunctionApr 16, 2025Failure to Seal; Failure to Seal

    N/A

    Patient problems: Cerebrospinal Fluid Leakage

    MAUDE report 21851690 ↗
  • InjuryApr 16, 2025Failure to Seal; Failure to Seal

    N/A.

    Patient problems: Cerebrospinal Fluid Leakage

    MAUDE report 21851274 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K032693. One submission often covers many models, so check the product and lot details in each record.

  • Z-1284-2013 · Mar 28, 2013 · Terminated
    DuraGen Plus Dural Regeneration Matrix DuraGen Plus Adhesion Barrier Matrix is an absorbable implant for repair and restoration of dural defects and as an adhesion barrier for the

Other DURA SUBSTITUTE devices

All DURA SUBSTITUTE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page